Protecting Infants from Serious RSV Illness

Respiratory Syncytial Virus (RSV) is a common virus that typically causes mild, cold-like symptoms in older children and adults. However, in infants, it can lead to serious lower respiratory tract infections such as bronchiolitis and pneumonia, potentially requiring hospitalization and respiratory support. Nearly all children contract RSV by age two, but the first year of life is particularly vulnerable.

While premature infants and those with pre-existing conditions like heart or lung disease are at higher risk, severe RSV can also affect otherwise healthy, full-term babies. Doctors note that the illness's gradual onset, often mistaken for a common cold, can lead to a rapid decline in breathing within days. This progression can necessitate intensive care, including ventilation.

Recent advancements offer hope beyond supportive care, with preventive immunisation-based strategies now available. These methods aim to reduce the risk of severe RSV disease and subsequent hospitalizations. Parents are encouraged to discuss these preventative options with their pediatrician shortly after their baby is born to safeguard their infant's health during their crucial first year.

Basic hygiene measures, coupled with timely preventive immunisation, are essential for protecting infants. Early protection before symptoms appear is key to mitigating the risk of severe illness. By increasing awareness and utilizing available preventative measures, the impact of severe RSV disease can be significantly lessened, ensuring infants have a healthier start.